Am J Perinatol 2016; 33(09): 839-843
DOI: 10.1055/s-0036-1572541
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Evaluating the Obstetrical Implications of Antenatal Testing for Women with Morbid Obesity: Maternal and Fetal Outcomes of Increased Surveillance

P. Kaitlyn Edelson
1   Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
,
Jamie A. Bastek
1   Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
,
Lisa D. Levine
1   Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
› Author Affiliations
Further Information

Publication History

20 April 2015

24 December 2015

Publication Date:
09 March 2016 (online)

Abstract

Objectives Despite limited data, antenatal testing has been initiated in many institutions for women with morbid obesity given their increased risk of stillbirth. Therefore, our objective was to evaluate the obstetrical implications of antenatal testing in the morbidly obese population.

Study Design We performed a retrospective cohort study of women undergoing antenatal testing from January 2011 through December 2012 who delivered at our institution. The exposed group was women undergoing antenatal testing with morbid obesity (body mass index [BMI] ≥ 40 kg/m2). This group was subdivided into two groups: group 1, which included women undergoing testing for morbid obesity alone, and group 2, which included women undergoing testing for morbid obesity with an additional medical comorbidity. The unexposed group (group 3) comprised nonmorbidly obese women (BMI < 35 kg/m2) undergoing antenatal testing for similar medical comorbidities. Our primary outcomes were induction of labor and gestational age at delivery.

Results A total of 512 women met inclusion criteria. Group 1 had a lower induction rate as compared with groups 2 and 3 (22.2, 32.5, and 37.6%, respectively; p = 0.003). Additionally, women delivered at a later gestational age in group 1 (39.3 weeks [38.4–40.2]) compared with groups 2 (38.5 weeks [36.1–40.3]) or 3 (37.1 weeks [37.0–38.2]), p = 0.04. There were no significant differences in our secondary outcomes including rate of cesarean delivery (p = 0.11) or rate of nonreactive nonstress test (p = 0.4).

Conclusions While it remains unknown whether antenatal testing decreases the stillbirth risk in morbidly obese women, this population does not appear to be at increased risk of induction of labor or delivery prior to 39 weeks secondary to testing. Future studies should evaluate neonatal implications and cost-effectiveness of antenatal testing in this group.

 
  • References

  • 1 Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002; 288 (14) 1728-1732
  • 2 American College of Obstetricians and Gynecologists. ACOG Committee Opinion number 315, September 2015. Obesity in pregnancy. Obstet Gynecol 2005; 106 (3) 671-675
  • 3 Catalano PM. Management of obesity in pregnancy. Obstet Gynecol 2007; 109 (2, Pt 1): 419-433
  • 4 Briese V, Voigt M, Wisser J, Borchardt U, Straube S. Risks of pregnancy and birth in obese primiparous women: an analysis of German perinatal statistics. Arch Gynecol Obstet 2011; 283 (2) 249-253
  • 5 Vasudevan C, Renfrew M, McGuire W. Fetal and perinatal consequences of maternal obesity. Arch Dis Child Fetal Neonatal Ed 2011; 96 (5) F378-F382
  • 6 Chu SY, Kim SY, Lau J , et al. Maternal obesity and risk of stillbirth: a metaanalysis. Am J Obstet Gynecol 2007; 197 (3) 223-228
  • 7 Gunatilake RP, Smrtka MP, Harris B , et al. Predictors of failed trial of labor among women with an extremely obese body mass index. Am J Obstet Gynecol 2013; 209 (6) 562.e1-562.e5
  • 8 Kugelman A, Colin AA. Late preterm infants: near term but still in a critical developmental time period. Pediatrics 2013; 132 (4) 741-751
  • 9 Tita AT, Landon MB, Spong CY , et al; Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med 2009; 360 (2) 111-120
  • 10 Fox NS, Rebarber A, Silverstein M, Roman AS, Klauser CK, Saltzman DH. The effectiveness of antepartum surveillance in reducing the risk of stillbirth in patients with advanced maternal age. Eur J Obstet Gynecol Reprod Biol 2013; 170 (2) 387-390
  • 11 Mackeen AD, Edelson PK, Wisch S, Plante L, Weiner S. Antenatal testing in uncomplicated pregnancies: should testing be initiated after 40 or 41 weeks?. J Perinat Med 2015; 43 (2) 233-237
  • 12 Levine LD, Srinivas SK, Paré E, Mehta-Lee SS. The impact of antenatal testing for advanced maternal age on cesarean delivery rate at an urban institution. Am J Perinatol 2015; 32 (1) 101-106
  • 13 Brown S, Wolfe MD, Coalson R, Myers OB, Rayburn WF. Maternal obesity and nonstress testing. Am J Perinatol 2011; 28 (9) 723-728